Seattle biotech InduPro Secures $77 Million in Latest Series B Funding Round

Seattle biotech InduPro secured $77 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

Seattle biotech InduPro Raises $77 million in Funding

Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline. [.] InduPro Raises $77M Series B for Proximity-Guided Therapeutics InduPro raised $77M Series B led by The Column Group for its proximity-guided platform that maps cell-surface protein pairs for selective cancer and autoimmune drugs.

Investors Behind the Funding

The round was backed by The Column Group. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Seattle biotech InduPro operates in Healthcare & Life Sciences. Seattle biotech InduPro's financing adds to recent private-market activity.

Strategic Use of Funds

advance cancer treatment pipeline

Looking Ahead

Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline

Source reference: original announcement/article.